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Aims: This meta-analysis aimed to define the perioperative risk of mortality in patients with 
alcoholic liver disease (ALD) undergoing extrahepatic gastrointestinal surgery. 
Methods: Systematic searches of Embase, Medline and CENTRAL were undertaken to 
identify studies reporting about patients with ALD undergoing extrahepatic gastrointestinal 
surgery published since database inception to January 2019. Studies were only considered if 
they reported on mortality as an outcome.  Pooled analysis of mortality was stratified as 
benign and malignant surgery; and specific operative procedures where feasible. 
Results: Of the 2899 studies identified only five studies met inclusion criteria. The operative 
procedures undertaken were cholecystectomy(n=1), umbilical hernia repair(n=1) and 
oesophagectomy(n=3). The total number of patients with ALD studied were 172. Therefore, 
any study on liver disease patients undergoing extrahepatic surgery that crucially included a 
subset with alcohol aetiology were included as a secondary analysis even though they failed 
to stratify mortality by underlying aetiology. The total number of studies that met this 
expanded inclusion criteria was 62, reporting on 37,703 patients with liver disease of which 
1735 (4.5%) had a definite diagnosis of ALD.  Meta-analysis of proportions of in-hospital 
mortality in patients with ALD undergoing upper gastrointestinal cancer surgery 
(oesophagectomy) was 23% (95% CI 14-35% I2=0%). In-hospital mortality following 
oesophagectomy in liver disease patients of all aetiologies was lower, 14% (95% CI 9-21% 
I2=41.1%). 
Conclusion: Postoperative in-hospital mortality is high in patients with liver disease and ALD 
in particular. However, the currently available evidence on ALD is limited and precludes 




Alcoholic liver disease is an increasing global public health problem due to excessive alcohol 
consumption, especially in European countries.(Marcellin and Kutala, 2018, Byass, 2014) 
The incidence of alcoholic liver disease in Europe was estimated as 14-26 per 100, 000 
population(Zatonski et al., 2010) and median prevalence estimated as 312 per 100,000 
population (Pimpin et al., 2018). However, given significant variation in international 
reporting global incidence is likely to be underestimated. Instead mortality from alcoholic 
liver cirrhosis is often used as the proxy for burden of alcoholic liver disease.(Rehm et al., 
2013) The World Health Organisation (WHO) recognises alcohol, as one of the major 
behavioural risk factors driving the global rise of non-communicable diseases.(WHO, 2018, 
Forouzanfar et al., 2016) Alcohol consumption and alcoholic liver disease are both 
associated with an increased risk of extrahepatic gastrointestinal cancers such as 
oesophageal, gastric, pancreatic and colorectal cancer.(Bagnardi et al., 2015, Kalaitzakis et 
al., 2011, Jepsen et al., 2016) They are also associated with an increased risk of benign 
conditions such as choleliathiasis and abdominal wall herniae.(Bouchier, 1969, Acalovschi et 
al., 1991, Acalovschi, 2014, Conte et al., 1999, Gray et al., 2008) The definitive management 
of these conditions often requires surgical intervention. However, surgery in the population 
of patients with alcoholic liver disease is reportedly associated with a higher risk of 
morbidity and mortality.(Garrison, 1984, Mansour et al., 1997) 
A review of surgical risk in patients with liver disease published in 1999 suggested that 
almost all the available data on the risk of surgery in patients with liver disease pertained to 
liver cirrhosis only, with the risk of mortality in patients with less severe variants of alcoholic 
liver disease completely unaddressed.(Friedman, 2010) There are even fewer studies 
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specifically evaluating surgical risk based on the different underlying aetiology such as viral 
and alcohol related liver disease.(Kalaitzakis et al., 2011) There is global consensus on the 
rise of alcohol use disorders as well as benign and malignant alcohol related gastrointestinal 
disease. (WHO, 2018, Forouzanfar et al., 2016) This therefore warrants contemporary 
surgical risk and outcomes assessment in this particular at risk group.   
Studies from the 1980’s suggested that the presence of liver cirrhosis was a contraindication 
to major gastrointestinal surgery such as laparotomy for elective or emergency 
presentations.(Garrison, 1984) However, with the advent of laparoscopic and minimal 
access surgery, it is unknown if the postoperative risk of mortality remains the 
same.(Puggioni and Wong, 2003, Lopez-Delgado et al., 2016)  The aim of this systematic 
review was to identify the available evidence, critically appraise it, synthesis the findings and 
quantify the mortality risk in patients with alcoholic liver disease undergoing extrahepatic 






The systematic review was conducted according to the Preferred Reporting Items for 
Systematic Reviews and Meta-Analysis (PRISMA) statement.(Liberati et al., 2009) 
 
Literature search 
Systematic searches of Medline, EMBASE, Cochrane Library databases, WHO International 
Clinical Trials Registry Platform (ICTRP) and Clinical trials.gov were undertaken to identify 
studies reporting postoperative outcomes in patients with alcoholic liver disease published 
from database inception to January 25th 2019. Only abdominal wall and extrahepatic 
gastrointestinal surgical procedures were considered, including oesophagectomy; 
gastrectomy; cholecystectomy; pancreaticoduodenectomy; appendicectomy and colonic 
resectional surgery. The abdominal wall procedures were any open or laparoscopic repair of 
ventral, inguinal, femoral and incisional herniae. The detailed search strategy is presented in 
Appendix 1. The search terms included: [‘alcohol(ic) liver disease’ OR ‘alcohol(ic) cirrhosis’] 
AND [(‘umbilical’ ‘paraumbilical’ ‘ventral’ ‘incisional’ ‘inguinal’ ‘femoral’) - hernia(e)’) OR 
((‘oesophageal’ ‘pancreas’ ‘gallbladder’ ‘colon’ ‘rectum’) - surgery’)]  mapped to 
corresponding Medline Subject Headings (MeSH). Hand searches of thesis repositories and 
reference lists of relevant studies were undertaken to ensure comprehensive inclusion.  
 
Inclusion criteria  
The titles and abstracts of studies identified from the searches were screened for suitability 
independently by two authors (AA and DJH) and any discordant articles adjudicated by (JW). 
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For a study to meet the eligibility criteria (Appendix 2), they had to be in adult human 
subjects, reporting on patients with alcoholic liver disease undergoing extrahepatic 
gastrointestinal surgery or abdominal wall surgery. The studies had to report on mortality as 
an outcome. This group of studies formed the primary analysis group.  Another group which 
comprised of all studies reporting on patients with liver disease undergoing extrahepatic 
surgery but crucially including patients with alcoholic liver disease and reporting on 
mortality but failing to stratify mortality outcomes by aetiology  were included as the 
secondary analysis group. (See Appendix 2) All full text published randomized controlled 
trials (RCT), nationwide population-based studies and prospective or retrospective 
observational studies were eligible for qualitative synthesis and quantitative meta-analysis.  
 
Exclusion criteria 
Studies reporting liver surgery, liver transplant or shunt related surgery were excluded. 
Studies on liver disease in children, or with no patients with an alcoholic aetiology, for 
example reporting on only non-alcoholic fatty liver disease (NAFLD), viral or autoimmune 
liver diseases were also excluded. Animal studies, case reports and case series (defined as 
number of study participants <10), meeting abstracts and publications for which the full text 
was irretrievable (with no full publication available from authors), letters, comments and 
editorials were excluded. No language limitation were applied. 
 
Data Extraction 
Data were extracted by two reviewers independently (AA and LB) into predefined templates 
and adjudicated by a third reviewer (DJH) to resolve any discrepancies. Data were collected 
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for type of study, country of origin, number of patients in the respective studies, and 
separately for the number of the study population with liver disease, and for the number 
with alcohol aetiology. For population-based studies, data were also collected for the 
databases used and the years of inclusion.  
The primary outcome was 30-day mortality. Secondary outcome was in-hospital mortality. 
Where feasible this was assessed in the primary analysis group of only patients with 
alcoholic liver disease and in the secondary analysis group of all liver disease patients who 
also included patients with an alcohol aetiology. 
 
Statistical analysis 
To quantify 30-day and in-hospital mortality after surgery in alcoholic liver disease we 
conducted a meta-analysis of proportions based on the number of deaths at 30-days or in-
hospital as reported in each study. A Freeman-Tukey transformation was used to establish a 
variance of the raw proportions of each study.(Nyaga et al., 2014) The transformed 
proportions were then pooled using a random effects model to account for the anticipated 
clinical and statistical heterogeneity of the included studies.   
It was agreed a priori to divide studies into the broad categories of benign and malignant. 
Thereafter, studies on benign surgery were subgrouped into their individual procedural 
types: appendicectomy, cholecystectomy, hernia repair. In pooling of data, the plan was to 
analyse stratified for the individual operative procedure. However, in the absence of enough 
data points, studies on benign surgery were pooled together.  
For malignant disease, studies were classified and quantitatively analysed as either upper 
gastrointestinal or lower gastrointestinal. Upper gastrointestinal surgery included 
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oesophagogastric operations and hepatobiliary pancreatic procedures. Whilst Lower 
gastrointestinal included surgery for all cancers of the colon. However, to account for 
studies that did not describe a single type of procedure and or included a mix of benign and 
malignant conditions – a separate category of mixed gastrointestinal was also reported.   
Groups and stratifications for data analysis were: 
 Benign 
o Abdominal Wall hernia 
o Appendicectomy 
o Cholecystectomy 
o Hernia repair 
 Malignant 
o Upper gastrointestinal  
o Lower gastrointestinal  
 Mixed gastrointestinal  surgery 
 
The amount of statistical heterogeneity of the included studies was evaluated using the I² 
statistic. An I² less than 25% was considered to indicate low heterogeneity and an I² > 75% 
to indicate high statistical heterogeneity.(Melsen et al., 2014)  All analyses were performed 
using Stata version 15.  
 
Risk of bias 
Risk of bias in included RCTs was analysed independently by two review authors (AA and LB) 
using the Cochrane Collaboration tool for assessing the risk of bias in randomized trials. For 
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non-randomised studies, the Newcastle-Ottawa Scale quality assessment were used to 
assess the risk of bias. All studies are reported as low, moderate or high risk of bias.  
 
Publication bias 
Publication bias was assessed by visual assessment of asymmetry in the funnel plot of 
included studies that had a comparator arm (surgical outcomes in liver disease or alcoholic 
liver disease versus general population).  
 
Protocol registration 
The protocol was registered with the PROSPERO database (www.crd.york.ac.uk/prospero)—





Characteristics of studies reporting on only Alcoholic Liver disease 
Of the 2899 studies identified, 97 full text articles were evaluated of which 5 studies met the 
inclusion criteria and formed the primary analysis group (appendix 2) Three studies included  
patients with alcoholic liver disease (Belghiti, 1990, Fekete, 1987, Pescovitz, 1984). Two 
additional studies included patients with all cause liver disease but reported mortality 
outcomes for patients with alcoholic liver disease separately.(Thulstrup, 2001, Lu et al., 
2005) Two studies originated from France (Belghiti, 1990, Fekete, 1987) and there was a 
single study each from Denmark, (Thulstrup, 2001), Taiwan(Lu et al., 2005) and the United 
States of America.(Pescovitz, 1984) The studies spanned a 21-year period from 1984 to 
2005.   
 
Patient characteristics 
The total number of patients studied were 172, number of men 117 (77.0%) and women 
55(33.0%). The mean age was 56.3 years. The operative procedures undertaken in these 
studies were cholecystectomy (n=1), umbilical hernia repair (n=1) and oesophagectomy 
(n=3). The three studies on oesophagectomy reported only in-hospital mortality. The two 
studies on benign surgery reported 30-day mortality with the study by Pescovitz also 
reporting a mean 18-month follow-up. The latter also reported early minor complications 
such as ascites fluid leak, and wound infections following umbilical hernia repair, with one 
mortality within the 90-day follow-up secondary to bleeding varices. The nationwide study 
by Thulstrup et al reported four deaths at the 30-day follow-up, from the 52 patients with 
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alcohol cirrhosis undergoing cholecystectomy compared to the 11 deaths in 1204 patients 
without cirrhosis. (Appendix 5-Table 2) 
 
Characteristics of studies in “all cause liver disease”   
 The total number of studies meeting the secondary inclusion criteria (Appendix 2), that is 
studies on liver disease patients including alcohol aetiology but not reporting mortality 
outcomes stratified by aetiology was 62 from the original 2899 studies identified. (Table 1).  
The studies originated from 16 countries across 4-continents with a widely different pattern 
of harmful alcohol consumption. Characteristics of the included studies are summarised in 
Table 1. 
The majority of the included studies 80.6%  (n=50/62) were single centre observational 
studies, 17.8% (n=11) were nationwide population-based reports and a single RCT (1.6%) 
was identified.(Ji, 2005)  The majority of studies 90.3% (n=56) were of moderate to high risk 
of bias. Reasons for high risk of bias included a lack of randomisation and a failure to 
describe adequately the methods of cohort identification. Only 15 studies (24.2%) were 
assessed as moderate risk of bias, and fewer still, 9.7% (n=6) were classified as low risk.   
The surgical procedures undertaken in the 62 included studies were open and laparoscopic 
cholecystectomy 34.9% (n=22), abdominal wall hernia repair 12.7% (n=8), appendicectomy 
1.6% (n=1), upper gastrointestinal surgery 15.9% ((n=10), which included 
oesophagogastrectomy (n=5), peptic ulcer surgery (n=1) and pancreaticoduodenectomy 
(n=4)), lower gastrointestinal surgery for cancer 9.5% (n=6). The number of studies that 
described a mixed variety of surgical procedures without separating out the individual 




The total number of patients in this expanded criteria of studies were 3.6-million, and this 
included 37,703 patients with liver disease. Only 56 studies reported details on aetiology of 
liver disease and in these studies, 1735 (4.6% of the total liver disease patients) were 
reported to have a definitive diagnosis of alcoholic liver disease.  The mean age of patients 
with liver disease from all the included studies was 58.7 years. (10, 12, 19-78) In the studies 
that supplied gender distribution of their included patients, 20,086 patients were male in 
and 17, 312 were female.  
 
Crude Mortality risk in alcoholic liver disease patients  
A single study in the primary analysis group reported mortality at 30-days. (Thulstrup, 
2001)They included 52 patients with alcoholic cirrhosis versus 1204 patients without liver 
disease. In the group with alcoholic cirrhosis mortality at 30-days was 7.7% (4/52) it was 
lower in the general population without liver disease 0.9% (11/1204). They also did an 
additional analysis of 58 patients with non-alcohol related cirrhosis who had a mortality rate 
of 1.7% (1/58).  
 
Crude Mortality risk in all cause liver disease patients  
A total of 7 studies provided data on mortality at 30-days in patients with liver disease 
(secondary analysis group). The crude mortality at 30-days after benign surgery in patients 
with liver disease was 3.9% (30/763) and was 0.7% (434/62323) in the general population 
without liver disease.  After malignant surgery, crude mortality at 30-days was 17.8% 
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(824/4624) in patients with liver disease and 5.3% (28397/539074) in the general population 
without liver disease.   
 
Meta-analysis 
There was insufficient studies to undertake meta-analysis of 30-day mortality for benign or 
malignant surgery in patients with alcoholic liver disease. Pooled analysis of in-hospital 
mortality in this patient group was only possible for those undergoing upper gastrointestinal 
cancer surgery (oesophagectomy). (Figure 1).  Pooled 30-day and in-hospital mortality for 
the secondary analysis group (all cause liver disease) are summarised in Figure 2, Figure 3 
and Figure 4.   
 
Heterogeneity 
There is an expectation of clinical and statistical heterogeneity given the varying complexity 
of the surgical procedures undertaken, as well as the individual patients’ degree of 
underlying liver disease. This influenced the decision to employ a random effects model for 
this meta-analysis. Overall, the quantity of statistical heterogeneity was low to moderate for 
benign conditions and for upper gastrointestinal cancers. For lower gastrointestinal cancer, 
the high statistical heterogeneity precluded quantitative pooling.  
 
Publication bias 
All the studies with a comparison group (alcoholic liver disease/all cause liver disease versus 
general populations) were included in the analysis of publication bias. It demonstrated that  
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the odds ratio of mortality in patients with liver disease was higher in every study and every 
procedure considered, however the magnitude of the risk reported differed. (Appendix 4) 
The significant asymmetry seen even of studies of similar procedures suggests the possibility 
of underlying bias – pertaining not only to publication bias, but likely influenced by selection 




What this review found? 
There is a significant lack of evidence regarding the surgical outcomes of patients with 
alcoholic liver disease undergoing extrahepatic gastrointestinal surgery. We identified five 
studies reporting outcomes on 172 patients. Following expansion of the inclusion criteria to 
contain all studies where some patients had an alcohol aetiology, the total number of 
eligible studies increased but the total number with an alcoholic aetiology was small 1735 
out of 37,703 patients (4.6%). Alcoholic liver disease spans a spectrum of disease severity 
from simple steatosis to decompensated cirrhosis. However, in the currently available 
literature on surgery in this population, the range of alcoholic liver disease is not 
represented, with the majority of studies focusing solely on patients with cirrhosis.   
Mortality risk  (Meta-analysis of proportions) 
In the primary analysis group (studies reporting only alcoholic liver disease), it was not 
possible to determine 30-day mortality risk. In-hospital mortality could only be assessed in 
patients undergoing upper gastrointestinal cancer surgery, where the pooled mortality was 
23% (95% CI 14-35% I2=0%).  In the secondary analysis group, 30-day mortality was reported 
by less than a third of the included studies with the remainder reporting in-hospital 
mortality. Quantitative pooling of 30-day mortality risk could only be determined for those 
patients undergoing benign surgery and not for the individual procedural types.  
With regards the secondary outcome of in-hospital mortality, it was feasible to assess this 
for the majority of procedures. Specifically regarding cholecystectomy, the in-hospital 
mortality risk differed based on the patients studied. For example in studies where there 
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was selection of only patients with Child-Pugh A and B grade cirrhosis, the in-hospital 
mortality was 0% (I2=0%). However, in those that also included Child-Pugh C patients, or did 
not select out patients the in-hospital mortality was 3% (95% CI 1-6, I2=61.66%). The in-
hospital mortality risk after upper gastrointestinal cancer was much higher at 14% (95% CI 9-
21% I2=41.1%), reflecting the added complexity of these operations. 
 
What is already known?  
Postoperative mortality in patients with liver disease and alcoholic liver disease 
Cholecystectomy  
A Swedish nationwide population based study, which evaluated all cholecystectomies 
performed between 2007 and 2010 reported a 30-day mortality of 0.15% following the 
procedure in the general population.(Sandblom, 2015) They also reported a 2.2 fold 
increased risk of mortality in those undergoing an open cholecystectomy. Only one study 
reported 30-day mortality in patients undergoing cholecystectomy, and in that study crude 
mortality at 30-days was 7.7% in patients with alcoholic liver disease (Appendix 5-Table 2).  
In-hospital mortality, however, was 0% for those patients with Child-Pugh A and B cirrhosis, 
supporting the findings that laparoscopic cholecystectomy is feasible for these patients. The 
in-hospital mortality for studies that included Child C patients was 3%, which represents a 
20-fold increased risk of death when compared to the quoted mortality risk of 0.15% in the 






Hernia repair  
Elective hernia repair is overall a low risk procedure, where mortality risk is not raised above 
that of the background population.(Nilsson et al., 2007) Emergency surgery may increase 
the risk after hernia repair.(Basta et al., 2016) In this review, the individual studies reported 
30-day mortality risk that ranged from 1% (0-4%, Gray et al(Gray et al., 2008)) to 7%(5-9%, 
Saleh et al(Saleh et al., 2015)), Figure 1.   The in-hospital mortality risk was lower at 2%(1-
2%).  These findings are important as it reiterates the importance of understanding the 
consequences of surgery in patients with liver disease, beyond the initial in-hospital post-
operative period.  
 
Upper Gastrointestinal Surgery 
Morbidity and mortality after upper gastric cancer surgery is high even in patients who are 
fundamentally fit and well. The in-hospital mortality risk in this meta-analysis was 14% in 
the secondary analysis group, which is expectedly higher than was seen for patients 
undergoing benign surgery. The in-hospital mortality in those patients with alcoholic liver 
disease was higher still at 23%. No study provided data on 30-day mortality risk for this 
procedure. 
 
Lower Gastrointestinal Surgery 
The mortality risk after lower gastrointestinal cancer surgery, could not be formally pooled 
due to the high I2-values signifying significant statistical heterogeneity. However, in the 
individual studies, mortality at 30-days ranged from 1.8% to 16%. These mortality risk 
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identified in the individual studies are consistent with mortality risk published in the 
literature which suggest postoperative mortality of 1-5% in patients without liver disease 
and 6-41% in those with underlying liver disease.(Montomoli, 2013) 
 
Severity of alcoholic liver disease. 
Several studies in liver disease have suggested poor outcomes in patients with an alcohol 
aetiology when compared to patients with other causes of liver disease. It would appear the 
same phenomenon is also present in patients with an alcohol aetiology of liver disease 
undergoing general surgical procedures. Two population-based studies (Thulstrup, 2001, 
Montomoli, 2013), reported a much higher risk of mortality in patients with alcoholic liver 
disease undergoing cholecystectomy and colectomy when compared to patients with other 
aetiological causes of liver disease.  This was further demonstrated in the meta-analysis of 
proportions, where patients with alcohol aetiology undergoing upper gastrointestinal cancer 
surgery had a higher rate of mortality of 23% compared to 14% in the “all liver disease” 
population. These findings of poorer postoperative prognosis of patients with an alcohol 
aetiology remains interesting but it  would need further investigation and dedicated studies 
that are adequately powered to examine any true differences in outcomes for alcohol 




There is a lack of dedicated studies evaluating alcoholic liver disease patients undergoing 
gastrointestinal surgery. Only three studies contained a full cohort of patients with an 
alcohol aetiology and a further two had separated out outcomes based on aetiologies. Given 
the paucity of studies we had to accept all studies that included a subset of patients with an 
alcohol aetiology. However, even amongst these patients with liver cirrhosis those with an 
alcohol aetiology are few. Considering alcoholic cirrhosis accounts for the majority of cases 
of cirrhosis (approx. 60%) and contributes to 48% of deaths due to liver cirrhosis (Rehm et 
al., 2013), the small proportion currently studied may underestimate the true mortality risk 
after surgery in patients with alcoholic cirrhosis. Additionally, the currently available 
evidence focuses on liver cirrhosis which means the mortality risk in less severe alcoholic 
liver disease could not be explored.  
The studies included in this meta-analysis encompassed a wide window from 1980’s to 
2018, the evolution of surgical practice and 30-day mortality outcomes over  this time 
period could not be explored meaningfully due to the lack of relevant studies per individual 
procedure type and this is a potential bias in our mortality estimates. Additional 
confounding which could not be explored due to lack of patient level data is the potential of 
co-existent risk such as overall comorbidity and lifestyle risks such as obesity and smoking 
which are known to affect surgical outcomes.   
The lack of dedicated studies also meant that for patients with alcoholic liver disease, we 
could only undertake pooling of mortality data for those undergoing upper gastrointestinal 
cancer surgery, but not for benign or lower gastrointestinal cancer surgery.  For certain 
procedures, we could not undertake formal meta-analysis of the data due to the high 
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degree of statistical and plausibly clinical heterogeneity. Medical practices may vary 
regionally and the population characteristics, proportion with alcohol aetiology, the stage 
and grade of cancers (for malignant surgery) were all likely to vary and could have 
contributed to the heterogeneity. However, in the studies where pooling could be 
undertaken, patients undergoing surgical intervention had a demonstrable increased risk of 




Patients with alcoholic liver disease undergoing surgery have a high risk of in-hospital and 
30-day mortality. The currently available evidence is of low quality and are mostly single 
centre retrospective studies with an inherently higher risk of bias.  Alcoholic liver disease is 
increasing, and trial data are scarce, it therefore necessitates large population based studies 
to assess the risk of morbidity and mortality following gastrointestinal surgery and provide 
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Ji et al. 2005 China Cholecystectomy Total = 80 
LD = 80 
ETOH = 9 
Cirrhosis Child A (41) 
Child B (32) 
Child C (7) 
Meld = nr 
  SC Moderate 
Nationwide database study 





      
Carbonell et al. 2005 USA Ventral 
Hernia 
UHC Database Total =32,033 Cirrhosis Nr In-hospital 
mortality 
 MC Moderate 
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(1999-2004) LD = 1197 
ETOH = nr 
Meld = nr 




Total = 3240 
LD = 3240 
ETOH = 320 
Cirrhosis Nr 










Total = 2.8 million 
LD = 22569 
ETOH = nr 
Cirrhosis Nr 




Ecker et al. 2014 USA  
Hernia 
ACS – NSQiP 
(2009-11) 
Total = 138,366 
LD = 778 









Gray et al. 2008 USA Hernia VA NSQIP 
(1998-2002) 
Total = 1421 
LD = 127 
ETOH =24 
Cirrhosis Nr 




Hansen et al. 2002 Denmark Hernia DNHR 
(1993-1997) 
Total = 1300 
LD = 457 
ETOH = nr 
Cirrhosis Nr 










Total = 39840 
LD = 527 
ETOH =60 
LD, cirrhosis Nr 














Total = 503,583 
LD = 4042 
ETOH = nr 
Cirrhosis Nr 








Total = 688 
LD = 688 
ETOH =51 
Cirrhosis Nr 










Total = 1314 
LD = 110 
ETOH =52 
Cirrhosis Nr 









Total = 59051 
LD = 69 
ETOH = nr 
Cirrhosis Nr 





Befeler et al. 2005 USA Intra-abdo surgery 
-cholecystectomy 
-exploratory laparotomy 
Total = 53 
LD = 53 
ETOH =10 
 
Cirrhosis A (21) 
B (27) 
C (5) 




Belghiti et al, 1990 France Oesophagectomy Total = 32 
LD = 32 
ETOH =32 
Cirrhosis A (30) 
B (2) 







Binger et al, 2008 USA Laparoscopic 
cholecystectomy 
Total = 99 
LD = 99 
ETOH =38 
Cirrhosis Nr 
Meld =10.9  
Women 




Busquets et al. 2016 Spain Pancreaticoduodenectomy Total = 45 
LD = 15 
ETOH =6 
Cirrhosis A (n=15) 




Cappellani et al, 2008 Italy Laparoscopic 
cholecystectomy 
Total = 40 
LD = 40 
ETOH =7 
Cirrhosis A (20) 
B (10) 
C (10) 




Cobb et al. 2004 USA Laparoscopic 
cholecystectomy, 
colectomy, splenectomy 
Total = 50 
LD = 50 
ETOH =3 
Cirrhosis A (39) 
B (10) 
C (1) 




Cucinotta et al. 2003 Italy Cholecystectomy Total = 22 








Curro et al. 2005 Italy Cholecystectomy Total = 42 
LD = 42 
ETOH =7 








Meld = nr 
Curro et al. 2007 Italy Cholecystectomy Total = 50 
LD = 50 
ETOH =11 
Cirrhosis A (32) 
B (18) 




Da Silveira et al. 2006 USA Cholecystectomy Total = 99 








D'Albuquerque et al. 
1995 
Brazil Cholecystectomy Total = 12 








Delis et al. 2010 USA Cholecystectomy Total = 220 








Del Olmo et al. 2003 Spain Intra-abdominal surgery, 
hernia 
Total = 221 
LD = 135 
ETOH = nr 
Cirrhosis A (83) 
B (41) 
C (11) 




Dunnington et al. 1987 USA Cholecystectomy Total = 32 
LD = 32 
ETOH =22 
Cirrhosis A (6) 
B (14) 
C (2) 






Eker et al. 2011 Netherlands Umbilical hernia Total = 30 
LD = 30 
ETOH =7 
Cirrhosis A (6) 
B (19) 
C (5) 





Farnsworth et al. 2004 USA Abdominal and others Total = 40 
LD = 40 
ETOH =10 
Cirrhosis A (13) 
B (22) 
C (5) 





Fekete et al. 1987 France Oesophago-gastrectomy  Total = 23 
 
LD = 23 
ETOH =23 
Cirrhosis A (21) 
B (2) 





Fernandes et al. 2000 USA Cholecystectomy Total = 235 
LD = 48 
ETOH =26 
Cirrhosis A (38) 
B (10) 




Franzetta et al, 2003 Italy Extrahepatic surgery 
(cholecystectomy/colectom
y 
Total = 40 
LD = 40 
ETOH =7 
Cirrhosis A (14) 
B (13) 
C (13) 






Gervaz et al. 2003 USA Colectomy Total = 72 
LD = 72 
ETOH =35 
Cirrhosis A (31) 
B (30) 
C (11) 




Gil et al, 2003 Argentina Cholecystectomy Total = 15 
LD = 15 
ETOH =7 
Cirrhosis A (14) 
B (1) 




Guo et al. 2014 China Gastrectomy Total = 58 
LD = 58 
ETOH =1 
Cirrhosis A (25) 
B (31) 
C (2) 




Han et al. 2017 South Korea Colectomy for colorectal 
cancer 
Total = 275 
LD = 55 
ETOH =8 
Cirrhosis A (46) 
B (9) 




Hotiet et al. 2007 USA Mixed surgical procedures Total = 195 
LD = 195 
ETOH =35 
Cirrhosis A (41) 
B (115) 
C (39) 




Jang et al. 2008 South Korea Gastrectomy Total = 57 
LD = 57 
ETOH =22 
Cirrhosis A (46) 
B or C(11) 






Lehnert et al. 1993 Germany Laparotomy for peptic ulcer Total = 69 
LD = 69 
ETOH =32 
Cirrhosis Nr 




Leonie et al. 2001 Italy cholecystectomy Total = 96 
LD = 24 
ETOH =3 
Cirrhosis A (19) 
B (5) 




Levente et al. 2008 Belgium cholecystectomy Total = 52 
LD = 52 
ETOH =6 
Cirrhosis A (36) 
B (14) 
C (2) 




Lledo et al. 2011 Spain cholecystectomy Total = 503 
LD = 43 
ETOH =6 
Cirrhosis A (20) 
B (15) 
C (2) 




Lu et al, 2005 Taiwan Oesophagectomy Total = 16 
LD = 16 
ETOH =13 
 







Mansour et al. 1997 USA Intra-abdo surgery Total = 92 
LD = 92 
ETOH =44 








Meld = nr 
Metcalf et al. 1987 USA Colectomy for colorectal 
cancer 
Total = 54 
LD = 54 
ETOH =17 
Cirrhosis Nr 




Meunier et al. 2008 France Colectomy for colorectal 
cancer 
Total = 43 
LD = 43 
ETOH =39 
Cirrhosis A (17) 
B (21) 
C (5) 




Morino et al. 2000 Italy cholecystectomy Total = 33 
LD = 33 
ETOH =14 
Cirrhosis A (27) 
B (4) 
C (2) 




Neeff et al. 2014 Germany Intra abdominal surgery Total = 204 
LD = 204 
ETOH =109 
Cirrhosis A (79) 
B (78) 
C (47) 






Northup et al. 2005 USA Non-transplant surgery Total = 140 
LD = 140 
ETOH =39 
Cirrhosis Nr 






Oh et al, 2011 South Korea Hernia repair Total = 780 
LD = 129 
ETOH =15 
Cirrhosis A (45) 
B (66) 
C (18) 




Pescovitz et al. 1984 USA Umbilical hernia repair Total = 22 
LD = 22 
ETOH =22 
Cirrhosis Nr 







Poggio et al. 2000 USA Lap cholecystectomy Total = 50 
LD =50 
ETOH =13 
Cirrhosis A (39) 
B (11) 





Ramesh et al. 2008 India Pancreas surgery for chronic 
pancreatitis 
Total = 57 
LD = 57 
ETOH =28 
Steatosis, Cirrhosis Nr 




Regimbeau et al. 2015 France Pancreaticoduodenectomy Total = 105 
LD = 35 
ETOH =22 
Cirrhosis A (24) 
B (11) 








Song et al. 2011 South Korea Intra-abdominal surgery Total =  
LD = 98 
ETOH = 22 
Cirrhosis A (45) 
B (66) 
C (18) 






Tachibana et al. 2000 Japan Oesophagectomy Total = 245 
LD = 18 
ETOH =14 
Cirrhosis A (11) 
B (7) 




Teh et al. 2007$ USA Small and large bowel and 
spleen 
Total = 214 
LD = 214 
ETOH =42 
Cirrhosis Nr 









Telem et al. 2010 Canada Intra-abdominal operations Total = 100 
LD = 100 
ETOH =18 
Cirrhosis A (50) 
B (33) 
C (17) 
Meld = 12.4 
nr SC Moderate 
Tuech et al. 2002 France Lap cholecystectomy Total = 26 
LD = 26 
ETOH =14 
Cirrhosis A (22) 
B (4) 









LD = 32 
ETOH =27 
B (2) 
Meld = 11+/-5 
Yoshida et al. 2012 Japan Lap Splenectomy Total = 60 
LD = 60 
ETOH =2 
Cirrhosis A (24) 
B (33) 
C (3) 




Zarski et al, 1988 France Mixed Gastrointestinal 
surgery 
Total = 67 
LD = 67 
ETOH =48 
Cirrhosis Child-Pugh scores 




Ziser et al. 1999 USA Multitude of operations Total = 733 
LD = 733 
ETOH =224 
Cirrhosis Child-Pugh Scores 






UHC - University Health-System Consortium (UHC), formed in 1984, is an alliance comprised of 129 academic medical centers. 
NIS - Nationwide Inpatient Sample (United States of America) The NIS is the largest all-payer inpatient care database in the US, collecting information   
on all discharges from approximately 20% of the nation’s hospitals every year. It is supported by the Healthcare Cost and Utilization Project and contains all-payer discharge information for 100% of 
patient discharges from participating hospitals.  
DNHR – Danish National Hospital Registry, contains information on all hospital admissions since 1977 
DNRP - Danish National Registry of Patients. The DNRP includes information on all nonpsychiatric hospitalizations since 1977 and on outpatient contacts since 1995 
nr – not reported 
SC – single centre 
MC – multicentre 
NW – Nationwide population based 
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Veterans Affairs NSQIP - Veterans’ Affairs National Surgical Quality Improvement Program at 16 hospitals  
AICP – Alcohol induced chronic pancreatitis 
$ - STUDY Provided data on hepatic resection, and other procedures which were not part of this study inclusion 
Fekete/PESCOVITCH/ BELGHITI - 100% alcoholics 
GI – gastrointestinal 
Saleh study – ascites but including patients with alcohol cirrhosis as well as congestive cardiac failure etc 
NEEF – is one of the few retrospective studies that included a follow-up longer than a year, indeed he covered a 5yr follow-up. 
In patients with a CTP C the survival fell to 20% at one year, it was 50% at one year in CTP B and 70% in CTPA patients undergoing gastrointestinal surgery. Montomoli and Muenier analysed patients as either alcohol 
cirrhosis and cirrhosis of any other cause and both concluded that patients with alcohol cirrhosis  had worse outcomes 
 
 
(Ji, 2005, Carbonell et al., 2005, Chmielecki, 2012, Csikesz, 2009, Ecker, 2014, Gray et al., 2008, Hansen et al., 2002, Montomoli, 2013, Nguyen, 
2009, Saleh et al., 2015, Thulstrup, 2001, Poulsen et al., 2000, Befeler et al., 2005, Belghiti, 1990, Bingener, 2008, Busquets, 2016, Cappellani, 
2008, Cobb et al., 2005, Cucinotta, 2003, Curro, 2005, Curro et al., 2007, da Silveira, 2006, D'Albuquerque, 1995, Delis, 2010, del Olmo et al., 
2003, Dunnington, 1987, Eker et al., 2011, Farnsworth et al., 2004, Fekete, 1987, Fernandes et al., 2000, Franzetta, 2003, Gervaz, 2003, Gil, 
2003, Guo, 2014, Han, 2017, Hoteit et al., 2008, Jang, 2008, Lehnert and Herfarth, 1993, Leone, 2001, Dery, 2008, Lledo, 2011, Lu et al., 2005, 
Mansour et al., 1997, Metcalf, 1987, Meunier, 2008, Morino, 2000, Neeff et al., 2014, Northup et al., 2005, Oh et al., 2011, Pescovitz, 1984, 
Poggio, 2000, Ramesh, 2008, Regimbeau et al., 2015, Song, 2011, Tachibana, 2000, Teh, 2007, Telem et al., 2010, Tuech, 2002, Warnick et al., 























Legend: Meta-analysis of proportions of in-hospital mortality after upper gastrointestinal 
cancer surgery –(all oesophagectomy) in only patients with definitive diagnosis of 

















Legend: Meta-analysis of proportions of 30-day mortality after benign gastrointestinal surgery, including 










































Legend: Meta-analysis of proportions of in-hospital mortality after benign gastrointestinal surgery. 
Cholecystectomy – includes studies where all child’s grade of cirrhosis are included. Cholecystectomy A&B 










Legend: Meta-analysis of proportions of in-hospital mortality after upper gastrointestinal cancer surgery – 















Proportion of deaths in all cause liver disease 
